TherapeuticsMD Stock Overlap Studies Parabolic SAR Extended

Key Indicators . Data . Stocks . USA . 
Stock . TherapeuticsMD
TXMD Stock  USD 1.97  0.01  0.51%   
This overlap studies analysis applies Parabolic SAR Extended study to TherapeuticsMD, capturing moving averages and envelope bands overlaid on TherapeuticsMD's price chart to identify support, resistance, and trend direction. Enter Start Value, Offset on Reverse, AF Init Long, AF Long, AF Max Long, AF Init Short, AF Short, and AF Max Short to generate the indicator output.

Study
Start Value
Offset on Reverse
AF Init Long
AF Long
AF Max Long
AF Init Short
AF Short
AF Max Short
Execute Study
This analysis covers sixty data points across the selected time horizon. The Extended Parabolic SAR indicator is used to determine the direction of TherapeuticsMD's momentum and the point in time when it has higher than normal probability of directional change. It has more input parameters than standard Parabolic SAR indicator.

TherapeuticsMD Technical Analysis Modules

Technical analysis of TherapeuticsMD uses historical price and volume data to identify patterns that may signal where the TherapeuticsMD trend is heading. When multiple indicator categories align on the same directional signal for TherapeuticsMD, confidence in the setup increases.
Cycle Indicators
Math Operators
Math Transform
Momentum Indicators
Overlap Studies
Pattern Recognition
Price Transform
Statistic Functions
Volatility Indicators
Volume Indicators

Technical Indicator Methodology & Signal Interpretation

Overlap studies for TherapeuticsMD layer smoothed price lines and envelope bands over the chart to identify support, resistance, and trend direction. Multiple confirming signals across categories increase analytical confidence.

TherapeuticsMD analytics rely on periodic company reporting and market reference feeds, with quality checks and normalization applied.

Editorial review and methodology oversight provided by: Rifka Kats, Member of Macroaxis Editorial Board

Tools
Analysis
Directory
Company
2026 Macroaxis LLC Made with in San Francisco
Privacy Terms Widgets Feedback
Macroaxis is not a registered investment advisor or broker/dealer. All investments, including stocks, funds, ETFs, or cryptocurrencies, are speculative and involve substantial risk of loss. We encourage our investors to invest carefully. Much of our information is derived directly from data published by companies or submitted to governmental agencies which we believe are reliable, but are without our independent verification. Therefore, we cannot assure you that the information is accurate or complete. We do not in any way warrant or guarantee the success of any action you take in reliance on our statements or recommendations. Also, note that past performance is not necessarily indicative of future results. All investments carry risk, and all investment decisions of an individual remain the responsibility of that individual. There is no guarantee that systems, indicators, or signals will result in profits or that they will not result in losses. All investors are advised to fully understand all risks associated with any investing they choose to do. Hypothetical or simulated performance is not indicative of future results. We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown because hypothetical or simulated performance is not necessarily indicative of future results. For more information please visit our terms and conditions page.